Avacopan
treatment
1 mentions
1 recordings
first heard Aug 2026
last heard 14 Aug
↑1 vs the 12 months before
Phase‑III trial of a C5a receptor inhibitor for vasculitis
Trend
Peak in the week of 14 Aug — 1 mentions across 1 series.
Moments
newest first · ▶ plays the momentAshley ElliottTalking Rheumatology Spotlight · Ep 55: A spotlight on vasculitis and the kidneys · 14:45 · 14 Aug
…And I suppose talking about a avacopan, so obviously there's a couple of recent things that have come up out of Acapan and just if we talk about the um the trial data that supports its use and it's placed then in practice, and then kind of just talking about um recent safety reviews of its treatment, and where where do you see evapopan's place in treatment a…
All 1 moments